Co-Diagnostics, Inc. Common Stock (NASDAQ: CODX) last traded at $1.21, up 5.22% on the session. The quote above updates while this page is open; the figures below are drawn from Co-Diagnostics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Co-Diagnostics, Inc. Common Stock trades on NASDAQ under the ticker CODX. Its market capitalisation is $7.57 million.
Valuation measures for Co-Diagnostics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $7.57M |
|---|---|
| Enterprise value | $7.79M |
| Price / sales | 10.49 |
| Price / book | 0.60 |
| Beta | 3.12 |
Trailing-twelve-month figures tagged in Co-Diagnostics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $721.4K |
|---|---|
| Net income (TTM) | -$47.06M |
| Gross margin | 43.48% |
| Operating margin | -6787.59% |
| Return on equity | -370.16% |
| Cash | $3.65M |
Range and volume for CODX over the past 52 weeks.
| 52-week high | $46.50 |
|---|---|
| 52-week low | $0.940 |
| Volume | 292.3K |
| Average volume | 2.04M |
| Previous close | $1.15 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.